Evidence map›Paper›PMID 33177607›Full record

ArticleScientific reports2020

Association between mental health comorbidity and health outcomes in type 2 diabetes mellitus patients.

Inmaculada Guerrero Fernández de Alba, Antonio Gimeno-Miguel, Beatriz Poblador-Plou, Luis Andrés Gimeno-Feliu, Ignatios Ioakeim-Skoufa, Gemma Rojo-Martínez, Maria João Forjaz, Alexandra Prados-Torres

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Inmaculada Guerrero Fernández de AlbaEpiChron Research Group, IIS Aragón, Teaching Unit of Preventive Medicine and Public Health, Zaragoza, Spain.
Antonio Gimeno-MiguelEpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Health Services Research On Chronic Patients Network (REDISSEC), Miguel Servet University Hospital, 50009, Zaragoza, Spain. agimenomi.iacs@aragon.es.
Beatriz Poblador-PlouEpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Health Services Research On Chronic Patients Network (REDISSEC), Miguel Servet University Hospital, 50009, Zaragoza, Spain.
Luis Andrés Gimeno-FeliuEpiChron Research Group, IIS Aragón, REDISSEC, University of Zaragoza, Servicio Aragonés de Salud (SALUD), Primary Care Health Centre San Pablo, 50009, Zaragoza, Spain.
Ignatios Ioakeim-SkoufaEpiChron Research Group, IIS Aragón, 50009, Zaragoza, Spain. ignacio.ioakim@hotmail.es.
Gemma Rojo-MartínezRegional University Hospital of Málaga, Endocrinology and Nutrition Department, IBIMA, University of Malaga, CIBERDEM, 29010, Málaga, Spain.
Maria João ForjazNational Centre of Epidemiology, Institute of Health Carlos III, REDISSEC, 28029, Madrid, Spain.
Alexandra Prados-TorresEpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Health Services Research On Chronic Patients Network (REDISSEC), Miguel Servet University Hospital, 50009, Zaragoza, Spain.
Instituto de Investigación Sanitaria Aragón · ESInstituto de Investigación Biomédica de Málaga · ESInstituto de Salud Carlos III · ESServicio Aragonés de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2D) is often accompanied by chronic diseases, including mental health problems. We aimed at studying mental health comorbidity prevalence in T2D patients and its association with T2D outcomes through a retrospective, observational study of individuals of the EpiChron Cohort (Aragón, Spain) with prevalent T2D in 2011 (n = 63,365). Participants were categorized as having or not mental health comorbidity (i.e., depression, anxiety, schizophrenia, and/or substance use disorder). We performed logistic regression models, controlled for age, sex and comorbidities, to analyse the likelihood of 4-year mortality, 1-year all-cause hospitalization, T2D-hospitalization, and emergency room visit. Mental health comorbidity was observed in 19% of patients. Depression was the most frequent condition, especially in women (20.7% vs. 7.57%). Mortality risk was higher in patients with mental health comorbidity (odds ratio 1.24; 95% confidence interval 1.16-1.31), especially in those with substance use disorder (2.18; 1.84-2.57) and schizophrenia (1.82; 1.50-2.21). Mental health comorbidity also increased the likelihood of all-cause hospitalization (1.16; 1.10-1.23), T2D-hospitalization (1.51; 1.18-1.93) and emergency room visit (1.26; 1.21-1.32). These results suggest that T2D healthcare management should include specific strategies for the early detection and treatment of mental health problems to reduce its impact on health outcomes.

Indexed as

AdolescentAdultAgedAged, 80 and overComorbidityDepressionDiabetes Mellitus, Type 2Emergency Service, HospitalFemaleHospitalizationHumansMaleMental HealthMiddle AgedPrevalenceSchizophrenia

Identifiers

PMID33177607
PMCPMC7658226
OpenAlexW3099673536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.